HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Optic neuritis treatment trial. One-year follow-up results.

AbstractOBJECTIVE:
To determine the efficacy of corticosteroids as treatment for acute demyelinative optic neuritis after completion of 1 year of patient follow-up in the Optic Neuritis Treatment Trial.
DESIGN:
Randomized placebo controlled multicenter clinical trial.
SETTING:
Fifteen university or hospital-based centers throughout the United States.
PATIENTS:
Four hundred fifty-seven patients with acute demyelinative optic neuritis between 18 and 46 years of age.
INTERVENTION:
Either intravenous methylprednisolone sodium succinate (250 mg every 6 hours) for 3 days followed by oral prednisone (1 mg/kg per day) for 11 days, oral prednisone (1 mg/kg per day) for 14 days, or oral placebo for 14 days. The first two regimens were followed by a short taper of corticosteroid therapy.
MAIN OUTCOME MEASURES:
Visual acuity, visual field, contrast sensitivity, and color vision.
RESULTS:
Visual acuity at 1 year was 20/40 or better in 95% of the placebo group, 94% of the intravenous group, and 91% of the oral prednisone group. Comparing each corticosteroid group with the placebo group, there were no statistically significant differences in the distributions of any of the four measures of visual function. Patients in the oral prednisone group suffered a higher rate of new attacks of optic neuritis than patients in either of the other two groups.
CONCLUSIONS:
The visual benefit from treating acute optic neuritis with intravenous followed by oral corticosteroids is short term, limited to an accelerated rate of recovery. The decision whether to prescribe this regimen for optic neuritis, or to prescribe no treatment, must be made for each patient on an individual basis. Oral prednisone alone, in the dose range used in the Optic Neuritis Treatment Trial, should not be prescribed.
AuthorsR W Beck, P A Cleary
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 111 Issue 6 Pg. 773-5 (Jun 1993) ISSN: 0003-9950 [Print] United States
PMID8512477 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Prednisone
  • Methylprednisolone
Topics
  • Acute Disease
  • Administration, Oral
  • Adolescent
  • Adult
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Infusions, Intravenous
  • Male
  • Methylprednisolone (administration & dosage, therapeutic use)
  • Middle Aged
  • Optic Neuritis (drug therapy)
  • Prednisone (administration & dosage, therapeutic use)
  • Vision, Ocular

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: